A multinational manufacturer of cardiovascular devices recently engaged SeerPharma to conduct a comprehensive mock US FDA audit of their operations in Singapore. The audit was conducted against US FDA 21 CFR Part 820 – Quality System Regulation (21 CFR 820). SeerPharma reviewed relevant documentation remotely and then spent three days on-site...
GMP Training in Singapore with Temasek Polytechnic
May
17,
2018
SeerPharma have partnered with Temasek Polytechnic’s Centre of Innovation for Complementary Health Products (COI-CHP), to assist companies involved with Pharmaceuticals, Biologicals, Complementary Medicines, Traditional Chinese Medicine and Cosmetics, help ensure their Facilities and Operations are GMP compliant; their products are manufactured...
2017 PDA Modern Biopharmaceutical Processing Conference
September
21,
2017
The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance...